October 22, 2013
A New Jersey federal judge on Monday tossed a consolidated putative class action against Columbia Laboratories Inc., saying there's no proof behind the allegation that the company knew Prochieve, its drug for preventing premature birth, wouldn't secure regulators' approval, yet misled investors about the drug's prospects.
August 12, 2013
Columbia Laboratories Inc. fired back Friday in New Jersey federal court against consolidated investor claims that the company and its executives inflated its stock by talking up its premature-birth-preventing drug Prochieve despite allegedly knowing regulators would not approve it, saying the claims lack support.
February 03, 2012
Pharmaceutical company Columbia Laboratories Inc., whose touted premature-birth-preventing drug recently failed to win a key U.S. approval, was hit with a class action Friday by an investor who claims he was misled by the company's early hype.